When is it safe to stop for safety?

J Thromb Haemost. 2012 Jun;10(6):1188-90. doi: 10.1111/j.1538-7836.2012.04725.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants / adverse effects*
  • Cause of Death
  • Clinical Trials Data Monitoring Committees* / standards
  • Clinical Trials, Phase III as Topic / methods*
  • Clinical Trials, Phase III as Topic / standards
  • Early Termination of Clinical Trials
  • Evidence-Based Medicine
  • Hemorrhage / chemically induced*
  • Hemorrhage / mortality
  • Humans
  • Patient Safety* / standards
  • Practice Guidelines as Topic
  • Recurrence
  • Research Design* / standards
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Venous Thromboembolism / drug therapy*
  • Venous Thromboembolism / mortality

Substances

  • Anticoagulants